InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Wednesday, 01/06/2021 11:37:05 AM

Wednesday, January 06, 2021 11:37:05 AM

Post# of 248
Genome Stocks are the next FANG stocks according to Kathy Woods of ARKG. This stock is a $1.00 from its ALL TIME HIGH.

one of my top picks for 2021

Evogene’s CPB based solutions utilize comprehensive and integrated computational biology to provide life-science companies with tailor-made solutions for product discovery and development.
Microbes, small molecules and genetic genome elements can be applied to a wide variety of products within human health, agriculture and industrial applications.



EVGN WEBSITE:
https://www.evogene.com/


REHOVOT, Israel, Jan. 5, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments, provided today a year-end update for the CRISPR-IL consortium, of which it is a member and Evogene's CSO, Dr. Eyal Emmanuel, serves as the consortium's Chairman. The CRISPR-IL consortium, which is supported by the Israeli Innovation Authority, was established to develop an artificial intelligence-based system, for CRISPR-CAS based workflows, "Go-Genome", providing end-to-end genome-editing, with improved precision and efficiency.
https://www.biospace.com/article/releases/evogene-provides-2020-year-end-update-for-crispr-il-consortium/

Kathy Woods of ARKG ETF has been buying EVGN
Kathy woods from ARKG all star stock picker best in class.


https://ark-funds.com/arkg

EVGN Biz Presentation
https://www.evogene.com/wp-content/uploads/2020/05/Evogene_Investor_PPT_May-2020-file.pdf

EVGN Subsidiary's which they own close to 100% in all
https://www.evogene.com/subsidiaries/

(1) Biomica Human Microbiome (gene editing)

Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology.


(2).Canonic
Medical Cannabis

Canonic Mission: Commercialization of precise & stable medical cannabis products for better therapeutic effects.


(3)
AgPlenus
Ag-Chemicals

AgPlenus Mission: Design next generation effective, sustainable and safer crop protection products by leveraging predictive biology.


(4) Lavie Bio
Ag Biologicals

Lavie Bio Mission: Improve food quality, sustainability and agricultural productivity through the introduction of microbiome based ag-biological products.


(5)Castera
Castor Oil Production

Castera Mission: Provide farmers with the most advanced Castor seeds & Ag-service solutions

--------------------------------------------------------------------

2022 commercial product of a (Green) weed killer that will take market share from Monsanto round up


Oncology pipeline to kill tumors




https://www.tradingview.com/symbols/NASDAQ-EVGN/technicals/

Genome Stocks-Gene Editing.
$BEAM 5 billion market cap
$EDIT 5.1 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.4 billion market cap
$BLUE 3 billion market cap
$BNGO 850 million market cap

$EVGN 180 million market cap 35 million shares 45% owned by institutions & insiders
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News